Hocoma ArmeoSenso

ArmeoSenso (research version) is a sensor-based home therapy system for self-directed neurorehabilitation of the upper extremity. It was developed in the context of a collaboration between the University Hospital Zurich, the Balgrist University Hospital, ETH Zurich and Hocoma AG, supported by the Swiss Commission for Technology and Innovation. The system includes unique features, such as a pragmatic recalibration approach to cope with sensor limitations, clinical intelligence to detect and prevent compensatory movements, as well as assessment-driven difficulty adaptation, based on workspace and target reaching assessments. Feasibility was evaluated in a external pageclinical pilotcall_made, in which 11 stroke survivors used the system at home in an unsupervised manner over a period of six weeks, showing high overall acceptance and high therapy intensity in some users.